Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Association Between Prior Exposure to Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and Dengue Hospitalization in a Pediatric and Adolescent Population: A Nested Case-Control Post-Authorization Effectiveness Study

NCT06843226 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT06843226
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06843226 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Association Between Prior Exposure to Dengue Tetravalent Vaccine (Live, Attenuated) (TDV) and Dengue Hospitalization in a Pediatric and Adolescent Population: A Nested Case-Control Post-Authorization Effectiveness Study
Lead sponsor
Takeda
Phase
Observational
Overall status
Recruiting
Start date
March 5, 2025
Completion date
December 31, 2029
Enrollment
70,000 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

dengue fever